Search Results - G. Caleb Alexander

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis by Jeffrey R Curtis, G Caleb Alexander, Jiajun Wen, Hanzhe Zhang

    Published in RMD Open (2021-03-01)
    Get full text
    Article


  2. 2

    Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study. by Jingjing Sun, Hemalkumar B Mehta, Jodi B Segal, G Caleb Alexander

    Published in PLoS Medicine (2025-09-01)
    Get full text
    Article


  3. 3

    Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study. by Yunwen Xu, Scott J Pilla, G Caleb Alexander, Irene B Murimi

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  4. 4

    Branded prescription drug spending: a framework to evaluate policy options by Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar, Gerard Anderson

    Get full text
    Article


  5. 5

    Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study by G Caleb Alexander, Thomas J Moore, Stefan P Kruszewski, Phillip W Wirtz

    Published in BMJ Open (2021-08-01)
    Get full text
    Article


  6. 6

    Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis by G Caleb Alexander, Hemalkumar B Mehta, Thomas J Moore, Jodi B Segal

    Published in BMJ Open (2020-06-01)
    Get full text
    Article


  7. 7

    Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review by Thomas Metkus, Jill Curran, Shanshan Lin, Dima M. Qato, G. Caleb Alexander

    Published in American Heart Journal Plus (2024-02-01)
    Get full text
    Article


  8. 8

    Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis by G Caleb Alexander, Thomas J Moore, Phillip W Wirtz, Jill N Curran

    Published in BMJ Open (2023-04-01)
    Get full text
    Article


  9. 9

    Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review. by Carolyn Tieu, Eleanor J Lucas, Mindi DePaola, Lori Rosman, G Caleb Alexander

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  10. 10

    Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool by Jarett R. Beaudoin, MD, MPH, Jill Curran, MS, G. Caleb Alexander, MD, MS

    Published in AJPM Focus (2024-04-01)
    Get full text
    Article


  11. 11

    Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. by Sheriza N Baksh, Jodi B Segal, Mara McAdams-DeMarco, Rita R Kalyani, G Caleb Alexander, Stephan Ehrhardt

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  12. 12

    National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 by Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha

    Get full text
    Article


  13. 13

    High-dose opioid utilization and mortality among individuals initiating hemodialysis by Matthew Daubresse, G. Caleb Alexander, Deidra C. Crews, Dorry L. Segev, Krista Lentine, Mara A. McAdams-DeMarco

    Published in BMC Nephrology (2021-02-01)
    Get full text
    Article


  14. 14

    Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C) by Charles E Leonard, Ainhoa Gomez-Lumbreras, Daniel C Malone, Kathleen M Andersen, G Caleb Alexander, Olga V Kravchenko, Richard D Boyce, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Hemalkumar Mehta

    Published in BMJ Open (2022-12-01)
    Get full text
    Article


  15. 15

    Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United States by Alexander R. Zheutlin, Nasser Sharareh, Jenny S. Guadamuz, Ransmond O. Berchie, Catherine G. Derington, Joshua A. Jacobs, Favel L. Mondesir, G. Caleb Alexander, Emily B. Levitan, Monika Safford, Robert O. Vos, Dima M. Qato, Adam P. Bress

    Get full text
    Article


  16. 16

    Interventions to improve patient safety during the COVID-19 pandemic: a systematic review by Elliott R Haut, Albert W Wu, Renée F Wilson, G Caleb Alexander, Clare Rock, Neelam Dhingra-Kumar, David E Newman-Toker, William Padula, Kathryn McDonald, Rosemary Duncan, Allen Zhang, Katelyn Trigg, Sarah Fisseha, Joyce Black, Irina Papieva

    Published in BMJ Open Quality (2025-06-01)
    Get full text
    Article


  17. 17

    Deprescribing of antidepressants: development of indicators of high-risk and overprescribing using the RAND/UCLA Appropriateness Method by Vita Brisnik, Jochen Vukas, Caroline Jung-Sievers, Karoline Lukaschek, G Caleb Alexander, Ulrich Thiem, Petra Thürmann, Cornelius Schüle, Sebastian Fischer, Erika Baum, Michael Drey, Sebastian Harder, Wilhelm Niebling, Ulrike Janka, Olaf Krause, Jochen Gensichen, Tobias Dreischulte, for the POKAL-Group

    Published in BMC Medicine (2024-05-01)
    Get full text
    Article


  18. 18

    Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study by Kathleen M. Andersen, Corey S. Joseph, Hemalkumar B. Mehta, Michael B. Streiff, Joshua F. Betz, Robert C. Bollinger Jr, Arielle M. Fisher, Amita Gupta, Charles F. LeMaistre, Matthew L. Robinson, Yanxun Xu, Derek K. Ng, G. Caleb Alexander, Brian T. Garibaldi

    Get full text
    Article


  19. 19

    Effect of nirmatrelvir/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An electronic health record-based target trial emulation from N3C. by Abhishek Bhatia, Alexander J Preiss, Xuya Xiao, M Daniel Brannock, G Caleb Alexander, Robert F Chew, Hannah Davis, Megan Fitzgerald, Elaine Hill, Elizabeth P Kelly, Hemalkumar B Mehta, Charisse Madlock-Brown, Kenneth J Wilkins, Christopher G Chute, Melissa Haendel, Richard Moffitt, Emily R Pfaff, N3C Consortium

    Published in PLoS Medicine (2025-01-01)
    Get full text
    Article


  20. 20

    Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. by Catherine G Derington, Jordana B Cohen, April F Mohanty, Tom H Greene, James Cook, Jian Ying, Guo Wei, Jennifer S Herrick, Vanessa W Stevens, Barbara E Jones, Libo Wang, Alexander R Zheutlin, Andrew M South, Thomas C Hanff, Steven M Smith, Rhonda M Cooper-DeHoff, Jordan B King, G Caleb Alexander, Dan R Berlowitz, Faraz S Ahmad, M Jason Penrod, Rachel Hess, Molly B Conroy, James C Fang, Michael A Rubin, Srinivasan Beddhu, Alfred K Cheung, Weiming Xian, William S Weintraub, Adam P Bress

    Published in PLoS ONE (2021-01-01)
    Get full text
    Article


Search Tools: